Ammi visnaga (Visnaga daucoides) & Ammi majus as a novel thyrotherapeutic phytoa...
연구 요약
Ammi visnaga (Visnaga daucoides) & Ammi majus as a novel thyrotherapeutic phytoalternative for rat with L-thyroxine-induced hyperthyroidism.
Tissue & cell 학술지에 발표된 이 연구는 Nabil G, Shaalan M, Rashwan EH 외 연구팀이 수행하였습니다.
이 연구는 'Ammi visnaga (Visnaga daucoides) & Ammi majus as a novel thyrotherapeutic phytoalternative for rat with L-thyroxine-induced hyperthyroidism.'에 대한 과학적 분석을 제공합니다.
핵심 내용
Hyperthyroidism is a worldwide health problem mainly associated with potential health consequences such as heart failure, liver dysfunction, thyroid eye disease, hypercalcemia, hyperglycemia, dehydration & nervousness; moreover, it could turn into emergent thyrotoxicosis. Right now, there are limited options to regress hyperthyroidism, including surgery, ablation, & Thionamides, while each of them is fraught with risk, making the clinical decision very complicated. Thus, finding a sustainable, safe alternative with Thionamides' potency but with no/ limited adverse effects is a distinct clinical necessity. Hence, we investigate the antithyroid activity of two Apiaceae species, Ammi visnaga & Ammi majus, against L-thyroxine-induced hyperthyroidism. For this, the prepared methanolic extracts were tested at two upgrading doses (100 & 200 mg/kg), & the measured thyroid, metabolic, & liver parameters were compared to those of the negative, positive, & Propylthiouracil groups. Our results showed that both doses of both species effectively alleviate hyperthyroidism within a short time, as confirmed by histopathological & hormonal assessments. Strikingly, our study revealed that the low doses of both species acted only on the circulatory hormones (TSH, T4, & T3) without a significant impact on the glandular architecture. In contrast, the high doses of both species affected both the circulatory & glandular sides. This was reflected in the metabolic status, which showed normalization of calcium, cholesterol, & glucose levels, as well as improved weight gain. Regressing hyperthyroidism with both doses of the two species results in a significant improvement in liver profile, as indicated by ALT & AST levels. The impact of low & high doses of both species on thyroid, metabolic, & liver parameters was statistically significant compared to the reference groups. Therefore, we deduce that both species may be of medical relevance in combating hyperthyroidism with minimal repercussions.
일반인을 위한 해석
구체적인 실천 사항은 담당 의사 또는 약사와 상담하시기 바랍니다.
실천 사항
- 현재 복용 중인 약물이나 영양제에 대해 궁금한 점이 있다면 담당 의사 또는 약사와 상담하시기 바랍니다
- 약물이나 영양제의 용법·용량을 임의로 변경하지 마세요
- 이상 반응이 나타나면 즉시 전문가에게 문의하세요
의사/약사의 전문적 판단을 대체하지 않습니다 (PMID: 41762910)
이 연구와 관련된 약물을 복용 중인가요?
상호작용 체크하러 가기이 정보는 의학 논문의 요약이며, 의사/약사의 전문적 판단을 대체하지 않습니다.